GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Theravance, Inc. (THRX) [hlAlert]

Theravance, Inc. (Theravance) is a biopharmaceutical company with a pipeline of internally discovered product candidates. The Company is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas, including respiratory disease, bacterial
infections and gastrointestinal motility dysfunction. Its programs include telavancin for the treatment of serious Gram-positive bacterial infections with Astellas Pharma Inc. (Astellas) and its Horizon program and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program with GlaxoSmithKline plc (GSK). During the year ended December 31, 2008, Theravance owns 140 issued United States patents and 512 granted foreign patents. In addition, Theravance has 150 United States patent applications pending and 835 foreign patent applications pending as of December 31, 2008.
.
( Total: 12 Current Stock Recommendations )
Theravance, Inc.   (12)
Sell Hold 33% Buy 58%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
8/21/2007  
Buy
  
3/4/2008  
Hold
  
3/4/2008  
Buy
  
9/5/2008  
Buy
  
2/20/2009  
Buy
  
1/29/2010  
Hold
  
3/29/2010  
Buy
  
3/12/2012  
Buy
  
4/24/2013  
Hold
  
7/22/2013  
Sell
  
7/26/2013  
Buy
  
6/2/2014  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy